Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Davidson

Showing results (11-20 of 358) with videos related to

Pageof 36
Sort By:
The American Journal of Cardiology|December 17, 2008
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndromeMichael Davidson
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Cognitive impairment as a diagnostic criterion and treatment target in schizophreniaMichael Davidson
Cardiovascular Research|June 19, 2010
Endothelial mitochondria and heart diseaseSean Michael Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 14, 2023
Who has poor insight, my patient suffering from schizophrenia or myself?Michael Davidson, Ofer Agid
Expert Review of Endocrinology & Metabolism|August 1, 2018
Update on PCSK9 therapies for the treatment of dyslipidemiaAmita Singh, Michael Davidson
Dialogues in Clinical Neuroscience|August 16, 2024
Should dietary restrictions be imposed on Alzheimer's Disease patients affected by type 2 diabetes?Cristina Ștefănescu, Michael Davidson
Schizophrenia Bulletin|September 19, 2008
Using clinical data bases to study schizophreniaMark Weiser, Michael Davidson
Oncotargets and Therapy|December 10, 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesMichael Davidson, Naureen Starling
CNS Spectrums|July 27, 2004
Prodromal schizophrenia: the dilemma of prediction and early interventionMichael Davidson, Mark Weiser
International Journal of Geriatric Psychiatry|April 6, 2004
Emotional reactions of lay persons to someone with Alzheimer's diseasePerla Werner, Michael Davidson
Pageof 36

Showing results (11-20 of 358) with videos related to

Sort By:
Pageof 36
The American Journal of Cardiology|December 17, 2008
A review of the current status of the management of mixed dyslipidemia associated with diabetes mellitus and metabolic syndromeMichael Davidson
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 7, 2019
Cognitive impairment as a diagnostic criterion and treatment target in schizophreniaMichael Davidson
Cardiovascular Research|June 19, 2010
Endothelial mitochondria and heart diseaseSean Michael Davidson
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 14, 2023
Who has poor insight, my patient suffering from schizophrenia or myself?Michael Davidson, Ofer Agid
Expert Review of Endocrinology & Metabolism|August 1, 2018
Update on PCSK9 therapies for the treatment of dyslipidemiaAmita Singh, Michael Davidson
Dialogues in Clinical Neuroscience|August 16, 2024
Should dietary restrictions be imposed on Alzheimer's Disease patients affected by type 2 diabetes?Cristina Ștefănescu, Michael Davidson
Schizophrenia Bulletin|September 19, 2008
Using clinical data bases to study schizophreniaMark Weiser, Michael Davidson
Oncotargets and Therapy|December 10, 2016
Trastuzumab in the management of gastroesophageal cancer: patient selection and perspectivesMichael Davidson, Naureen Starling
CNS Spectrums|July 27, 2004
Prodromal schizophrenia: the dilemma of prediction and early interventionMichael Davidson, Mark Weiser
International Journal of Geriatric Psychiatry|April 6, 2004
Emotional reactions of lay persons to someone with Alzheimer's diseasePerla Werner, Michael Davidson
Pageof 36